{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006954",
      "entity_text" : "inflammation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00088",
      "entity_text" : "ICS",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Various clinical trials proved that ICS in Bronchial asthma significantly reduce the inflammation and hyper-responsiveness of airways, thereby improving lung function, decreasing the severity of symptoms and occurrence of acute exacerbation [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-03T09:34:58Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T09:29:07Z",
  "trigger" : "reduce",
  "evidence" : [ "ICS in Bronchial asthma significantly reduce the inflammation" ],
  "pmc_id" : "4319196",
  "score" : 0
}